• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1996 Fiscal Year Final Research Report Summary

Molecular design of low molecular fragments of complement regulatory factor for medical applications to zeno-transplantation and prevention of measles virus infection

Research Project

Project/Area Number 06557125
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section試験
Research Field Biological pharmacy
Research InstitutionHOKKAIDO UNIVERSITY

Principal Investigator

NAGASAWA Shegeharu  Hokkaido Univ., Fac.Pharm.Sci., Pro., 薬学部, 教授 (70029958)

Co-Investigator(Kenkyū-buntansha) MIYAGAWA Shuji  Osaka Univ.Dept.Med.Assist., 医学部, 助手 (90273648)
SEYA Tsukasa  Osaka Med.Ctr.Adult Dis.Chiet.Inv., 研究所, 主幹
NISHIMURA Hitoshi  Hokkaido Univ., Fac.Pharm.Sci.Assist., 薬学部, 助手 (80241347)
Project Period (FY) 1994 – 1996
KeywordsComplement / Regulatory factor / Zeno-transplantation / Measles virus / Active site / Gene technology
Research Abstract

Membrane cofactor protein, MCP,is a complement inhibitor, which prevents autologous complement attack to host cells. In addition, MCP is a receptor of measles virus. Low molecular active fragments of MCP seemed to be useful to prevent the hyper acute ejection of zeno-transplanted organs and measles virus infection. We have investigated the functional domains of MCP essential for the complement regulation and measles virus binding.
i : Functional sites of SCR of MCP
The extra cellular portion of MCP consisted of four tandem repeats of a domain nemed short consensus repeat (SCR). Experiments using biotechnological methods revealed that i ; SCR1 and 2 are essential for measles virus infection, ii ; SCR2 and 3 are essential for the ergulation of the complement activation through the classical pathway, iii ; SCR2,3, and 4 are essential for the regulation of the complement activation through the alternative pathway.
ii : Modulation of MCP functions by serine-threonine rich (ST) regions
The SCR region of MCP was followed by a short sequence rich in Ser/Thr. There are three isoforms of ST region, ST^<ABC>, ST^<BC>, and ST^C are expressed tissue-specifically. The sequence of measles virus infection and the regulatory function to the classical pathway of three ST-isoforms was ST^C>ST^<BC>>ST^<ABC>. On the other hand, the regulatory activity to the alternative pathway was ST^<ABC>>ST^<BC>>ST^C.
iii : Importance of the membrane fraction of MCP for measles virus infection
We designed a GPl-anchored form of MCP,which is devoid of membrane fraction and intracellular domain and binding to cell surface via glycosylated inositol. The GPl-anchored MCP did not mediate measles virus infection, indicating the importance of the membrane fraction of MCP for the internalization of measles virus.

  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Iwata. K. et al.: "Modulation of complement regulatory function and measles virus receptor function by the senine-threonine-enriched domain of membrane cofactor protein (CD46)." Biochem J.304. 169-175 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyagawa, S. et al.: "Effects of transfected complement regulatory proteins, MCP, DAF, and MCP-DAF hybrid, on complement-mediated swine endothelial cell lysis." Transplantation. 58. 834-840 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Seya, T. et al.: "Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against membrane cofactor protein of complement (CD46)." Immunology. 84. 619-625 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Seya, T. et al.: "Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement :; Identification of forms increased in cancer patients' sera." Int. Immunology. 7. 727-736 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Seya, T. et al.: "Human factor H and C4b-binding protein serve as factor-1・cofactors both envompassing inactication of C3b and C4b." Mol. Immunol.32. 355-360 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kurita, K.: "Human lymphocytes are more susceptible to measles virus than granulocytes, which is attributable to the phenotypic differences of their membrane cofactor protein (CD46)" Immunology letters. 48. 91-95 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Iwata. K.: "Diversity of sites for measles virus binding and for inactivation of complement C3b and D4b on membrane cofactor protein CD46." J. Biol. Chem.270. 15148-15152 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hirano, A. et al.: "Human cell receptor CD46 is down regulated through recognition of a membrane-proximal region of the cytoplasmic domain in persistent measles virus infection." J. Viol.70. 6929-6936 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Murakami, Y. et al.: "Molecular cloning of a complementary DNA for a membrane cofactor protein (MCP, CP46)/measles virus receptor on Vero cells and its functional characterization." Biol. Pharma. Bull.19. 1541-1545 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Seya, T. et al.: "The CD46 transmembrane domain is required for efficient formation of measles virus-mediated syncytium." Biochem. J.(印刷中). (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Iwata, K.et al.: "Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-enriched domain of membrane cofactor protein (CD46)." Biochem J.304. 169-175 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miyagawa, S.et al.: "Effects of transfected complement regulatory proteins, MCP,DAF,and MCP-DAF hybrid, on complement-mediated swine endothelial cell lysis." Transplantation. 58. 834-840 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Seya, T.et al.: "Blocking measles virus infection with a ecombinant soluble form of, or monoclonal antibodies against membrane cofactor protein of complement (CD46)." Immunology. 84. 619-625 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Seya, T.et al.: "Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement : Identification of forms increased in cancer patients' sera." Int.Immunology. 7. 727-736 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Seya, T.et al.: "Human factor H and C4b-binding protein serve as factor-l cofactors both encompassing inactivation of C3b and C4b." Mol.Immunol. 32. 355-360 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwata, K.: "Diversity of sites measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46." J.Biol.Chem.270. 15148-15152 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kurita, K.: "Human lymphocytes are more susceptible to measles virus than granulocytes, which is attributable to the phenotypic differences of their membrane cofactor protein (CD46)" Immunology letters. 48. 91-95 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hirano, A.et al.: "Human cell receptor CD46 is down regulated through recognition of a membrane-proximal region of the cytoplamsmic domain in persistent measles virus infection." J.Viol. 70. 6929-6936 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Murakami, Y.et al.: "Molecular cloning of a complementary DNA for a membrane cofactor protein (MCP,CD46) /measles virus receptor on Vero cells and its functional characterization." Biol.Pharma.Bull. 19. 1541-1545 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Seya, T.et al.: "The CD46 transmembrane domain is required for efficient formation of measles virus-mediated syncytium." Biochem.J.(in press). (1997)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-09  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi